Skip to main content

Classification of Brain Tumors by Nanopore Sequencing of Cell-Free DNA from Cerebrospinal Fluid

Tracking # 20-1169562

Price not reported

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Broadcasted Interactive Event
Dates Contact provider

Course overview

In our first virtual journal club, Ann-Kristin Afflerbach will discuss her recent article in Clinical Chemistry, the leading international journal of clinical laboratory science. She will share background information on brain tumor classification by genomic methods. She will also describe new technology for determining the genome-wide methylation of brain tumors and demonstrate the feasibility of their new approach to classifying brain tumors.

Subject areas

This course counts toward the state boards and subject areas below.

American Board of Clinical Chemistry

Clinical Chemistry Diplomate

1h Category 1

Molecular Diagnostics Diplomate

1h Category 1

Toxicological Chemistry Diplomate

1h Category 1

Florida Board of Clinical Laboratory Personnel

Clinical Laboratory Director

1h General (Molecular Pathology)

Clinical Laboratory Supervisor

1h General (Molecular Pathology)

Clinical Laboratory Technician

1h General (Molecular Pathology)

Clinical Laboratory Technologist

1h General (Molecular Pathology)

Public Health Director

1h General (Molecular Pathology)

Public Health Supervisor

1h General (Molecular Pathology)

Public Health Technologist

1h General (Molecular Pathology)

Disclosure statements

The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.


The following faculty reported financial relationships:

  • Jason Park, MD, PhD
  • Ownership Interest: OncoSeer Dx


The following faculty reported no relevant financial relationships:

  • Ann-Kristin Afflerbach, M.Sc.